Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiromi Kohmoto

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Ophthalmology (Auckland, N.Z.)|February 12, 2011
Divergence insufficiency associated with high myopiaHiromi Kohmoto, Kenji Inoue, Masato Wakakura
Neuro-Ophthalmology (Aeolus Press)|June 10, 2021
Clinical Features of Crowded Orbital Syndrome on Magnetic Resonance ImagingMayumi Iwasa, Masato Wakakura, Hiromi Kohmoto, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 14, 2012
Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapyKenji Inoue, Takayuki Fujimoto, Risako Higa, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 3, 2018
Switching from concomitant therapy to tafluprost/timolol fixed combinationKenji Inoue, Taku Kawashima, Seiki Katakura, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Ophthalmology (Auckland, N.Z.)|February 12, 2011
Divergence insufficiency associated with high myopiaHiromi Kohmoto, Kenji Inoue, Masato Wakakura
Neuro-Ophthalmology (Aeolus Press)|June 10, 2021
Clinical Features of Crowded Orbital Syndrome on Magnetic Resonance ImagingMayumi Iwasa, Masato Wakakura, Hiromi Kohmoto, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 14, 2012
Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapyKenji Inoue, Takayuki Fujimoto, Risako Higa, et al.
Clinical Ophthalmology (Auckland, N.Z.)|April 3, 2018
Switching from concomitant therapy to tafluprost/timolol fixed combinationKenji Inoue, Taku Kawashima, Seiki Katakura, et al.
Pageof 1